TOKYO, JAPAN – March 2, 2023 – Terumo Corporation today announced the establishment of global focus areas to further drive its diversity, equity and inclusion (DE&I) commitments across its worldwide operations.
The newly established focus areas are designed to guide Terumo's DE&I strategy globally, ensuring a consistent, coordinated approach to building an inclusive workplace culture across the company's operations in more than 160 countries and regions.
"Diversity, equity and inclusion are core to our ability to innovate and serve patients around the world," said a Terumo representative. "These focus areas will help ensure that our commitment to DE&I translates into concrete action across our global organization."
Terumo will work to implement these focus areas across its business units globally, reinforcing the company's commitment to fostering an inclusive environment for all associates.
About Terumo
Terumo (TSE: 4543) is a leading global provider of medical products and solutions with net sales of 4 billion USD. Founded in 1921, Terumo employs over 30,000 associates worldwide, and its products and services are available in more than 160 countries and regions. Terumo's stated mission is "Contributing to Society through Healthcare."
